Device
NeuroStar TMS
NeuroStar TMS is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
NCT01415154
completednot_applicable
Practical Application of Accelerated iTBS for MDD
NCT06113575
completednot_applicable
An Open Label Trial of TMS Therapy for Bipolar Depression
NCT02640950
Clinical Trials (3)
Showing 3 of 3 trials
NCT01415154Not Applicable
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
NCT06113575Not Applicable
Practical Application of Accelerated iTBS for MDD
NCT02640950Not Applicable
An Open Label Trial of TMS Therapy for Bipolar Depression
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3